Brian David Dynlacht

Brian David Dynlacht
Born(1965-09-03)September 3, 1965
Brooklyn, New York, United States
NationalityAmerican
Alma materYale University
University of California, Berkeley
Known forDiscovery of CP110
Identification of USP33
Awards
  • Presidential Early Career Award for Scientists and Engineers
  • Kenneth G. and Elaine A. Langone Damon Runyon Scholar Award
  • Pew Scholar in the Biomedical Sciences
  • Irma T. Hirchl Trust Career Award
Scientific career
FieldsBiochemistry
InstitutionsNew York University Grossman School of Medicine
Doctoral advisorRobert Tjian
Doctoral studentsNathan H. Lents

Brian David Dynlacht (born September 3, 1965), is an American biochemist and professor in the department of pathology of New York University Grossman School of Medicine at NYU Langone Health. Before moving his lab to New York University, he was an associate professor in the department of molecular and cellular biology at Harvard University. In 2002, while researching at the Harvard University, Dynlacht reported the discovery of CP110, which is now thought to be at the center of a molecular switch governing the centriole to ciliary transition in mammalian cells. His lab identified the first centriolar deubiquitinating enzyme, USP33, whose expression regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110, and thus regulates the centrosome duplication.